Day One Biopharmaceuticals
South San Francisco
About Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer, starting from the biology of childhood cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $687.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: nasdaq:DAWN
- Website: dayonebio.com
- Phone: +1 650 484 0899
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/day-one-biopharmaceuticals-48638 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.